TY - GEN
T1 - Silicon as a biomedical material
AU - Cheng, Mark Ming Cheng
AU - Tasciotti, Ennio
AU - Ferrari, Mauro
N1 - Funding Information:
These studies were supported by the following grants: DoDW81XWH-04-2-0035 Project 16 , DoDW81XWH-07-2-0101, DoDW31P4Q-07-1-0008, NASA SA23-06-017, State of Texas, Emerging Technology Fund, NIH NCI 1R21CA1222864-01, 1R01CA128797-01, and NSF ECCS-0725886. The authors would like to recognize the support from the Alliance for NanoHealth (ANH) and Center of Nanomedicine, The University of Texas Health Science Center at Houston.
Funding Information:
These studies were supported by the following grants: DoDW81XWH-04-2-0035 Project 16, DoDW81XWH-07-2-0101, DoDW31P4Q-07-1-0008, NASA SA23-06-017, State of Texas, Emerging Technology Fund, NIH NCI 1R21CA1222864-01, 1R01CA128797-01, and NSF ECCS-0725886. The authors would like to recognize the support from the Alliance for NanoHealth (ANH) and Center of Nanomedicine, The University of Texas Health Science Center at Houston.
Publisher Copyright:
© 2008 TRF.
PY - 2008
Y1 - 2008
N2 - The cornerstone of microelectronics and MEMS, silicon-based manufacturing is taking over as a fundamental material in medicine. Research and laboratory diagnostic uses of biomolecular array technologies and microfluidics are well established. Novel sensor nanotechnologies are demonstrating features that make them an indispensable tool for the conquest of the post-genomic challenges, which present astronomical complexities in their requirement for multiplexed, real-time analyses. Controlled-release nanofluidic and microchip devices are under development as drug-delivery implants. Recently, nano-porous silicon has emerged as a material for medicine itself: it is biodegradable with tunable kinetics, eminently biocompatible, and provides suitable drug loading and release rates. Formed into micro-and nanoparticles of ‘designer’ size, shape and surface properties, nanoporous silicon is a particularly versatile material for the next generation of nanomedical therapeutic products.
AB - The cornerstone of microelectronics and MEMS, silicon-based manufacturing is taking over as a fundamental material in medicine. Research and laboratory diagnostic uses of biomolecular array technologies and microfluidics are well established. Novel sensor nanotechnologies are demonstrating features that make them an indispensable tool for the conquest of the post-genomic challenges, which present astronomical complexities in their requirement for multiplexed, real-time analyses. Controlled-release nanofluidic and microchip devices are under development as drug-delivery implants. Recently, nano-porous silicon has emerged as a material for medicine itself: it is biodegradable with tunable kinetics, eminently biocompatible, and provides suitable drug loading and release rates. Formed into micro-and nanoparticles of ‘designer’ size, shape and surface properties, nanoporous silicon is a particularly versatile material for the next generation of nanomedical therapeutic products.
UR - http://www.scopus.com/inward/record.url?scp=85061933446&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061933446&partnerID=8YFLogxK
U2 - 10.31438/trf.hh2008.1
DO - 10.31438/trf.hh2008.1
M3 - Conference contribution
AN - SCOPUS:85061933446
T3 - Technical Digest - Solid-State Sensors, Actuators, and Microsystems Workshop
SP - 1
EP - 5
BT - 2008 Solid-State Sensors, Actuators, and Microsystems Workshop
A2 - Turner, Kimberly L.
A2 - Spangler, Leland
PB - Transducer Research Foundation
T2 - 2008 Solid-State Sensors, Actuators, and Microsystems Workshop
Y2 - 1 June 2008 through 5 June 2008
ER -